LAFAYETTE, La., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the ”Company” or ”Viemed”) (VMD), a national leader in respiratory care and
U.S. stock futures were lower this morning, with the Dow futures falling more than 100 points on Friday.
Shares of Ingles Markets, Incorporated IMKTA fell in t...
U.S. stock futures were slightly higher this morning, with the Nasdaq futures gaining around 0.2% points on Monday.
Shares of Super Micro Computer, Inc. SMCI f...
We came across a bullish thesis on Viemed Healthcare, Inc. (VMD) on Substack by Petty Cash. In this article, we will summarize the bulls’ thesis on VMD. Viemed Healthcare, Inc.
Net Revenue: $58 million, a company record for the third quarter.Sequential Revenue Growth: 6% increase from the previous quarter.Year-over-Year Revenue Growth
Nov 07, 2024 / 05:00PM GMTOperator Greetings and welcome to Vmed's third quarter, 2024 earnings conference call. At this time, all participants are on a listen-
Viemed Healthcare Inc (TSX:VMD) is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus estimate for Q3 2024 revenue is $0, and the earnings are ex
Net Revenue: $55 million for Q2 2024, a 27% increase from Q2 2023.Gross Margin: 60% for the quarter.EBITDA Margin: 23% for the quarter.Gross Profit: $32.9 mill
Aug 08, 2024 / 03:00PM GMTOperator Good day, ladies and gentlemen, and welcome to the VieMed second-quarter 2024 earnings call. Our host for today's call is Tod
As a concentrated equity manager, our performance is generated more so by our competence in curation, rather than the general vicissitudes of financial whims and tides.